Rocket Pharmaceuticals, Inc.
RCKT
$3.60
-$0.04-1.10%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -209.38M | -223.12M | -240.91M | -257.30M | -258.03M |
| Total Depreciation and Amortization | 10.18M | 11.03M | 11.17M | 10.32M | 10.11M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.56M | 30.35M | 34.93M | 36.06M | 33.62M |
| Change in Net Operating Assets | -9.98M | -8.26M | -7.30M | 7.12M | 5.64M |
| Cash from Operations | -179.62M | -190.01M | -202.12M | -203.80M | -208.66M |
| Capital Expenditure | -169.00K | -440.00K | -669.00K | -2.31M | -4.19M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 179.42M | 104.21M | 30.14M | 17.09M | 42.83M |
| Cash from Investing | 179.25M | 103.77M | 29.47M | 14.77M | 38.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.00K | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 182.85M | 183.03M | 184.56M |
| Repurchase of Common Stock | -67.00K | -67.00K | -67.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 215.00K | 215.00K | 215.00K | 215.00K | -- |
| Cash from Financing | 147.00K | 148.00K | 183.00M | 183.24M | 184.56M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -221.00K | -86.10M | 10.35M | -5.79M | 14.53M |